Luteolin Alleviates Liver Fibrosis in Rat Hepatic Stellate Cell HSC-T6: A Proteomic Analysis

References

• Dong S, Cai FF, Chen QL, et al. Chinese herbal formula Fuzheng Huayu alleviates CCL4-induced liver fibrosis in rats: a transcriptomic and proteomic analysis. Acta Pharmacol Sin. 2018;39(6):930–941. doi:10.1038/aps.2017.150
   PubMed Web of Science ®Google Scholar
• Thompson AI, Conroy KP, Henderson NC. Hepatic stellate cells: central modulators of hepatic carcinogenesis. BMC Gastroenterol. 2015;15:63. doi:10.1186/s12876-015-0291-5
   PubMed Web of Science ®Google Scholar
• Carloni V, Luong TV, Rombouts K. Hepatic stellate cells and extracellular matrix in hepatocellular carcinoma: more complicated than ever. Liver Int. 2014;34(6):834–843. doi:10.1111/liv.12465
   PubMed Web of Science ®Google Scholar
• Lee YA, Wallace MC, Friedman SL. Pathobiology of liver fibrosis: a translational success story. Gut. 2015;64(5):830–841. doi:10.1136/gutjnl-2014-306842
   PubMed Web of Science ®Google Scholar
• Semela D, Das A, Langer D, Kang N, Leof E, Shah V. Platelet-derived growth factor signaling through ephrin-b2 regulates hepatic vascular structure and function. Gastroenterology. 2008;135(2):671–679. doi:10.1053/j.gastro.2008.04.010
   PubMed Web of Science ®Google Scholar
• Yagai T, Miyajima A, Tanaka M. Semaphorin 3E secreted by damaged hepatocytes regulates the sinusoidal regeneration and liver fibrosis during liver regeneration. Am J Pathol. 2014;184(8):2250–2259. doi:10.1016/j.ajpath.2014.04.018
   PubMed Web of Science ®Google Scholar
• Yin C, Evason KJ, Asahina K, Stainier DY. Hepatic stellate cells in liver development, regeneration, and cancer. J Clin Invest. 2013;123(5):1902–1910. doi:10.1172/JCI66369
   PubMed Web of Science ®Google Scholar
• Chen XF, Ji S. Sorafenib attenuates fibrotic hepatic injury through mediating lysine crotonylation. Drug Des Devel Ther. 2022;16:2133–2144. doi:10.2147/DDDT.S368306
   PubMed Web of Science ®Google Scholar
• Liu X, Mi X, Wang Z, et al. Ginsenoside Rg3 promotes regression from hepatic fibrosis through reducing inflammation-mediated autophagy signaling pathway. Cell Death Dis. 2020;11(6):454. doi:10.1038/s41419-020-2597-7
   PubMed Web of Science ®Google Scholar
• Zhan SS, Jiang JX, Wu J, et al. Phagocytosis of apoptotic bodies by hepatic stellate cells induces NADPH oxidase and is associated with liver fibrosis in vivo. Hepatology. 2006;43(3):435–443. doi:10.1002/hep.21093
   PubMed Web of Science ®Google Scholar
• Canbay A, Feldstein AE, Higuchi H, et al. Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression. Hepatology. 2003;38(5):1188–1198. doi:10.1053/jhep.2003.50472
   PubMed Web of Science ®Google Scholar
• Llovet JM, Ricci S, Mazzaferro V, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008;359(4):378–390. doi:10.1056/NEJMoa0708857
   PubMed Web of Science ®Google Scholar
• Chen XF, Wang Y, Ji S, et al. Hepatoprotective efficacy and interventional mechanism of Qijia rougan decoction in liver fibrosis. Front Pharmacol. 2022;13:911250. doi:10.3389/fphar.2022.911250
   PubMed Web of Science ®Google Scholar
• Narisu B, Han Z. Effect of deduhonghua-7 powder on the liver function and fibrosis in rats with experimental liver Fibrosis. J Tradit Chin Med. 2012;2012:1.
   Google Scholar
• Gao LN, Yan K, Cui YL, Fan GW, Wang YF. Protective effect of Salvia miltiorrhiza and Carthamus tinctorius extract against lipopolysaccharide-induced liver injury. World J Gastroenterol. 2015;21(30):9079–9092. doi:10.3748/wjg.v21.i30.9079
   PubMed Web of Science ®Google Scholar
• Fu H, Liu X, Jin L, et al. Safflower yellow reduces DEN-induced hepatocellular carcinoma by enhancing liver immune infiltration through promotion of collagen degradation and modulation of gut microbiota. Food Funct. 2021;12(21):10632–10643. doi:10.1039/d1fo01321a
   PubMed Web of Science ®Google Scholar
• Chen Z, Liu L, Liu Y, et al. Hydroxysafflor yellow A induces autophagy in human liver cancer cells by regulating Beclin 1 and ERK expression. Exp Ther Med. 2020;19(4):2989–2996. doi:10.3892/etm.2020.8552
   PubMed Web of Science ®Google Scholar
• Ao H, Feng W, Peng C. Hydroxysafflor yellow a: a promising therapeutic agent for a broad spectrum of diseases. Evid Based Complement Alternat Med. 2018;2018:8259280. doi:10.1155/2018/8259280
   PubMed Web of Science ®Google Scholar
• Min F, Sun H, Wang B, et al. Hepatoprotective effects of hydroxysafflor yellow A in D-galactose-treated aging mice. Eur J Pharmacol. 2020;881:173214. doi:10.1016/j.ejphar.2020.173214
   PubMed Web of Science ®Google Scholar
• Wu S, Yue Y, Tian H, et al. Carthamus red from Carthamus tinctorius L. exerts antioxidant and hepatoprotective effect against CCl(4)-induced liver damage in rats via the Nrf2 pathway. J Ethnopharmacol. 2013;148(2):570–578. doi:10.1016/j.jep.2013.04.054
   PubMed Web of Science ®Google Scholar
• Menggensilimu HY, Zhao C. Anti-liver fibrosis effect of total flavonoids from Scabiosa comosa Fisch. ex Roem. et Schult. on liver fibrosis in rat models and its proteomics analysis. Ann Palliat Med. 2020;9(2):272–285. doi:10.21037/apm.2020.02.29
   PubMed Web of Science ®Google Scholar
• Ma JN, Bolraa S, Ji M, He QQ, Ma CM. Quantification and antioxidant and anti-HCV activities of the constituents from the inflorescences of Scabiosa comosa and S. tschilliensis. Nat Prod Res. 2016;30(5):590–594. doi:10.1016/j.jep.2013.04.054
   PubMed Web of Science ®Google Scholar
• Ji J, Yu Q, Dai W, et al. Apigenin alleviates liver fibrosis by inhibiting hepatic stellate cell activation and autophagy via TGF-beta1/Smad3 and p38/PPARalpha pathways. PPAR Res. 2021;2021:6651839. doi:10.1155/2021/6651839
   PubMed Web of Science ®Google Scholar
• Chen CY, Peng WH, Wu LC, Wu CC, Hsu SL. Luteolin ameliorates experimental lung fibrosis both in vivo and in vitro: implications for therapy of lung fibrosis. J Agric Food Chem. 2010;58(22):11653–11661. doi:10.1021/jf1031668
   PubMed Web of Science ®Google Scholar
• Domitrovic R, Jakovac H, Tomac J, Sain I. Liver fibrosis in mice induced by carbon tetrachloride and its reversion by luteolin. Toxicol Appl Pharmacol. 2009;241(3):311–321. doi:10.1016/j.taap.2009.09.001
   PubMed Web of Science ®Google Scholar
• Nakayama A, Morita H, Nakao T, et al. A food-derived flavonoid luteolin protects against angiotensin II-induced cardiac remodeling. PLoS One. 2015;10(9):e0137106. doi:10.1371/journal.pone.0137106
   PubMed Web of Science ®Google Scholar
• Dong S, Chen QL, Song YN, et al. Mechanisms of CCL4-induced liver fibrosis with combined transcriptomic and proteomic analysis. J Toxicol Sci. 2016;41(4):561–572. doi:10.2131/jts.41.561
   PubMed Web of Science ®Google Scholar